Mutations with loss of heterozygosity in the MAX gene have been correlated with the development of pituitary neuroendocrine tumors (PitNETs), pheochromocytomas, and paragangliomas. This evidence concerns the gene MAX and hereditary pheochromocytoma-paraganglioma.